arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ARTIVION, INC.

AORT
$23.52 ▼ -0.62 (-2.57%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome

Analytical Summary

ARTIVION, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.1B
Dividend Yield —
Revenue Growth 11.3% ↘
Op. Margin -6.7% ↘
ROIC -1.2% ↘
FCF / Share $-0.25 ↘
Trailing P/E —
Price / Book 2.6x
FCF Yield —
Debt / Equity 0.82
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$125.76M
↑ +11.3% —
Net Income Profit after all expenses
$-13.51M
↓ -1053.4% —
Operating Margin Operating profit as % of sales
-6.7%
↓ -233.7% 51th
FCF / Share Free cash flow per share
$-0.25
↓ -73.7% —
Long-Term Debt Long-term obligations
$363.42M
↑ +68.8% —

Health Breakdown

Profitability ↑
39
Returns
48
Financial Health ↓
52
Cash Quality ↓
25

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters